Sadik Kassim
CSO/CTO (Genomic Medicines) @ Danaher Corporation
Industry: Healthcare
- CSO/CTO (Genomic Medicines) (Dec 2021 – Present)
- Advisor (Dec 2021 – Present)
- Chief Technology Officer (Oct 2019 – Dec 2021)
- Executive Director, Process Design (Jan 2019 – Sep 2019)
- Chief Scientific Officer (Mar 2018 – Jan 2019)
- Vice President, Process and Analytical Development (Feb 2017 – Feb 2018)
- Cell and Gene Therapies Unit (Head of Early Analytical Development) (Mar 2014 – Feb 2017)
- The Surgery Branch (Research Biologist) (Mar 2012 – Mar 2014)
- Discovery Immunology (Postdoctoral Research Fellow) (Jan 2011 – Feb 2012)
- Gene Therapy Program (Postdoctoral Research Fellow) (Aug 2007 – Jan 2011)
The Sarcastimatic™ Bio
Straight from a failed design thinking workshop, please welcome Sadik Kassim, CSO/CTO (Genomic Medicines) at Danaher Corporation, believes 'streamlining' means faxing faster. Currently reverse-engineering morale from VHS training tapes. Every sentence they speak sounds like it belongs on a lanyard badge.
Top Shooters
💬 Comments
No comments yet. Be the first to roast politely.
🌀 More Executives to Roast or Praise!
⚠️ Disclaimer: BossOrToss is a satirical, community-driven platform. Profiles are based on public information and user submissions, and all content is presented for entertainment purposes only. No factual assertions should be inferred — just sarcasm, vibes, and a sprinkle of truth.
If you notice an incorrect image, a broken profile, or you’re listed and want to request a correction, feel free to email us. We’re happy to keep things accurate, fair, and funny — with your help.